Wnt-4 signaling plays a critical role in kidney development and is associated with the epithelial conversion of the metanephric mesenchyme. Furthermore, secreted Frizzled-related proteins (sFRPs) that can bind Wnts are normally expressed in the developing metanephros, and function in other systems as modulators of Wnt signaling. sfrp-1 is distributed throughout the medullary and cortical stroma in the metanephros, but is absent from condensed mesenchyme and primitive tubular epithelia of the developing nephron where wnt-4 is highly expressed. In contrast, sfrp-2 is expressed in primitive tubules. To determine their role in kidney development, recombinant sFRP-1, sFRP-2 or combinations of both were applied to cultures of 13-dpc rat metanephroi. Both tubule formation and bud branching were markedly inhibited by sFRP-1, but concurrent sFRP-2 treatment restored some tubular differentiation and bud branching. sFRP-2 itself showed no effect on cultures of metanephroi. In cultures of isolated, induced rat metanephric mesenchymes, sFRP-1 blocked events associated with epithelial conversion (tubulogenesis and expression of lim-1, sfrp-2 and E-cadherin); however, it had no demonstrable effect on early events (compaction of mesenchyme and expression of wt1). As shown herein, sFRP-1 binds Wnt-4 with considerable avidity and inhibits the DNAbinding activity of TCF, an effector of Wnt signaling, while sFRP-2 had no effect on TCF activation. These observations suggest that sFRP-1 and sFRP-2 compete locally to regulate Wnt signaling during renal organogenesis. The antagonistic effect of sFRP-1 may be important either in preventing inappropriate development within differentiated areas of the medulla or in maintaining a population of cortical blastemal cells to facilitate further renal expansion. On the other hand, sFRP-2 might promote tubule formation by permitting Wnt-4 signaling in the presence of sFRP-1. Published by Elsevier Science Ireland Ltd.
Introduction
The morphogenesis of kidney requires reciprocal interactions between the metanephric mesenchyme and ureteric bud (Saxe Ân, 1987) . It is a relatively unique developmental process involving the epithelial conversion of blastemal stem cells within the metanephric mesenchyme to form the tubular epithelia of the nephron. There appear to be at least two distinct stages in this development based upon growth factor involvement: ®rst, compaction or condensation of the mesenchyme, which can be induced with ®bro-blast growth factor (FGF2; Perantoni et al., 1995) ; and then, epithelial conversion of the mesenchymal condensates, which requires additional soluble factors (Karavanova et al., 1996; Barasch et al., 1999; Plisov et al., 2001) . The complete process has been characterized by speci®c morphogenetic structures that arise following induction, i.e. condensed mesenchyme, pretubular aggregate of polarized cells, comma-shaped body, S-shaped body, and segmented tubule/nephron. While these events are induced by soluble signaling factors released from an apposing tissue, the ureteric bud, (Perantoni et al., 1995; Karavanova et al., 1996; Barasch et al., 1997) , epithelial conversion is thought to be mediated in the induced mesenchyme by a secreted patterning molecule derived from the mesenchyme itself, namely wnt-4 (Stark et al., 1994; Kispert et al., 1998) .
The wnt gene family consists of at least 16 different conserved glycoproteins that regulate pattern formation during embryogenesis (reviewed by Dale, 1998) . Results from expression and gene targeting studies indicate that Wnt-4 plays a critical role in renal tubule formation (Stark et al., 1994) . During the preliminary phases of morphogenesis, it is localized to mesenchymal condensates and primitive epithelia derived from the metanephric mesenchyme, while other kidney-expressed wnt molecules, e.g. wnt-7b or wnt-11, are detected only in the ureteric bud or interstitial stroma (Kispert et al., 1996; Karavanova et al., 1996) . Gene targeting of wnt-4 results in the formation of small undifferentiated renal rudiments, which show no evidence of tubulogenesis. In addition, the co-cultivation of metanephric mesenchyme with cells expressing wnt-4 induces tubule formation, although other ectopically-expressed Wnt molecules are equally ef®cient .
Wnt signaling is initiated in mammals by interaction of the Wnt protein with a homolog of the Drosophila gene family of frizzled receptors (Chan et al., 1992; Wang et al., 1996) . These membrane-bound proteins consist of a lengthy extracellular portion with a cysteine-rich domain (CRD), seven putative transmembrane segments, and an intracellular tail. Signaling is thought to be dependent upon the interaction of the Wnt ligand with the CRD (Hsieh et al., 1999) . In addition to the membrane-bound forms of Frizzled, several naturally occurring genes that encode soluble homologous proteins have also been identi®ed. These secreted Frizzled-related proteins (sFRPs) lack the seven transmembrane segments, but have a Frizzled-like CRD. Many of them have been shown to bind Wnt proteins, and can function as antagonists of Wnt activity (Moon et al., 1997; Rattner et al., 1997; Finch et al., 1997; Leyns et al., 1997; Wang et al., 1997) . The role of the sFRPs in organogenesis remains unknown, although there is evidence that they can modulate Wnt signaling during embryogenesis. Notably, Frzb-1 or sFRP-3 and sFRP-1 can inhibit Wntdependent axis duplication in Xenopus embryos (Finch et al., 1997; Leyns et al., 1997; Wang et al., 1997) . More recently, the inhibitory effect of sFRP-1 on Wnt-dependent axonal remodeling has been reported (Hall et al., 2000) .
At least three different sFRP family members thus far described have been implicated in renal organogenesis, and each family member shows a characteristically distinct, and often complementary, pattern of expression, involving stroma or epithelia (Leimeister et al., 1998; Lescher et al., 1998) . To determine a possible function for these proteins in renal organogenesis, we have evaluated the ability of sFRP-1 and sFRP-2 to modulate development in cultures of metanephric tissues. In these studies, sFRP-1 blocked tubule formation in metanephroi and isolated induced metanephric mesenchymes. Furthermore, sFRP-2 partially rescued tubulogenesis from inhibition by sFRP-1. Finally, sFRP-1 was found to interact directly with Wnt-4 and to inhibit the DNA-binding activity of T cell factor (TCF) in explanted metanephric mesenchymes.
Results

Expression of sfrp-1 and sfrp-2 in rat metanephros
To determine expression patterns of sfrp-1 and sfrp-2 in rat metanephroi, in situ hybridization was performed using thin sections from 16-and 19-dpc embryos, that correspond developmentally to 14-and 17-dpc mouse embryos. sfrp-1 expression in the developing rat kidney is similar, but not identical to that described for the mouse (Lescher et al., 1998) . In the 16-dpc rat kidney, sfrp-1 transcripts were most pronounced around the ureter, but high levels were also noted in all stromal elements, including the interstitial populations of the medulla and the outer layer of the cortex (Fig. 1A±C ). Epithelial structures of nephron or duct consistently failed to express this molecule. Neither was it expressed in condensed induced mesenchyme. In 19-dpc kidneys, a similar pattern was maintained, except that medullary expression was further increased (data not shown), and stromal elements remained the principal site of sfrp-1 expression. Epithelial structures showed no detectable levels of expression. Sections probed with sense transcripts of sfrp-1 or sfrp-2 yielded no signal (data not shown).
In 16-dpc kidneys, sfrp-2 expression occurred most prominently in the mesenchymal tissue surrounding the developing ureter (Fig. 1D,E ), which overlaps with one area noted for sfrp-1 expression. In other regions, the expression was complementary to that for sfrp-1. It was found in pretubular condensates (polarized epithelia) beneath the tip of the ureteric bud and in newly formed epithelia of the nephron (comma-and S-shaped bodies), but not in the bud itself or the condensed mesenchyme at the bud tip (Fig. 1F) . In 19-dpc rudiments (data not shown), expression occurred predominantly in the cortical nephrogenic zone in the same structures just described; however, it was diminished in more mature structures positioned near the medullary region. Glomeruli did not express sfrp-2. Therefore, sfrp-2 serves as an appropriate marker for newly formed epithelia in the metanephros.
Effects of sFRPs in cultures of metanephroi
To evaluate the effects of sFRPs in the metanephros, isolated rat metanephroi (13-dpc) were cultured for 5 days in medium containing 10% serum in the presence or absence of sFRPs. After ®xation, epithelial components (both the ureteric bud and newly formed tubule) were labeled with anti-E-cadherin (Rhodamine). The speci®city of this binding has been shown previously (Vestweber et al., 1985) . The ureteric bud was also stained with Dolichos bi¯orus (DB)-lectin (FITC). The speci®city of DB-lectin binding has been demonstrated previously (Laitinen et al., 1987) . The merged images distinguish newly formed tubules (red) from ureteric bud (yellow). In each treatment, three metanephroi were placed on the ®lter, and the experiment was repeated at least twice with similar results. Representative cultures are shown in Fig. 2 . In control cultures, the bud had branched repeatedly and extensive tubule formation occurred at the bud tips ( Fig. 2A,B) . sFRP-2 treatment did not change these phenotypes (data not shown). In the presence of 5 mg/ml of sFRP-1, although tubules were detected, bud growth and tubule formation were markedly inhibited (Fig. 2C,D) . This inhibitory effect of sFRP-1 was partially opposed by the addition of sFRP-2 (10 mg/ml; Fig. 2E,F) . A higher concentration of sFRP-1 (10 mg/ml) completely blocked both bud growth and tubulogenesis of the mesenchyme (Fig.  2G) ; however, the addition of sFRP-2 (10 mg/ml) rescued some branching and tubular morphogenesis, suggesting that sFRP-2 opposes the effect of sFRP-1 on Wnt-4 signaling.
Effect of sFRP-1 on morphogenesis of metanephric mesenchyme
To further de®ne the ability of the sFRP-1 protein to regulate molecular events in tubulogenesis, our well-characterized model system of explanted non-induced metanephric mesenchymes was used (Perantoni et al., 1995; Karavanova et al., 1996; Karavanov et al., 1998) . Mesenchymes were separated from the ureteric bud prior to induction and then placed on porous Nuclepore ®lters. When explants are incubated with an inductive medium (IM), which includes an aliquot of cell culture medium conditioned by a cell line derived from rat ureteric bud in combination with basic FGF2, they can be induced to differentiate completely, forming tubules and avascular glomeruli (Karavanova et al., 1996) . To test the effects of sFRP-1 on this differentiation, explant cultures were exposed to IM with or without various amounts of sFRP-1 (1.25±10 mg/ml). In cultures treated with IM alone, explants were replete with tubules after 72 h (Fig. 3A) . Under similar conditions, but with the addition of 10 mg/ml of sFRP-1, tubule formation was completely blocked without any apparent effect on the morphological condensation of the mesenchyme (Fig. 3B) . Epithelial structures were totally absent from these cultures. This could not be attributed to toxicity, since there was no evidence of necrosis in explanted tissues and numerous mitotic ®gures were apparent. Of 20 explants exposed to IM, all 20 showed extensive tubular development, while 20 additional explants exposed to IM plus sFRP-1 contained no demonstrable tubules. At 5 mg/ml of sFRP-1, an inhibitory effect on tubulogenesis was apparent but diminished.
Expression of early marker wt1 in sFRP-1-treated metanephric mesenchymes
Since the condensation of the mesenchyme, an early morphogenetic event in nephrogenesis, did not seem to be affected by sFRP-1 treatment, we evaluated the explants for the expression of wt1, a transcription factor that is up-regulated in the condensed mesenchyme. Gene targeting studies have shown that the expression of this gene is critical to the maintenance of the metanephric mesenchyme and its condensation (Kreidberg et al., 1993) . In explants, high levels of wt1 expression were observed in both sFRP-1 untreated ( Fig. 3C ,E) and treated ( Fig. 3D,F) cultures. In Fig. 3C ,E, sections of explants included both condensed and tubular areas, and expression was detected in the condensed, but not mature, tubular regions as occurs in vivo. In sFRP-1-treated explants, high levels of wt1 were noted throughout the large condensate, suggesting that treatment with this protein did not in¯uence the early events of differentiation.
Expression of late markers, lim-1, sfrp-2 and Ecadherin in sFRP-1-treated metanephric mesenchymes
To characterize the effect of sFRP-1 on late morphogenetic events, which include epithelial conversion and tubule formation, we analyzed the expressions of lim-1 and sfrp-2. The homeobox gene, lim-1, plays a signi®cant role in the development of the urogenital tract, as observed in null mutants which fail to form either kidneys or gonads (Shawlot and Behringer, 1995) . It is expressed in the developing metanephric mesenchyme, ®rst in pretubular condensates which consist of polarized epithelia, and subsequently in primitive tubules, but is absent from non-induced mesenchyme or mesenchymal condensates (Karavanov et al., 1998) . Thus, its expression is associated only with developing epithelia. In explants treated with IM, extremely high levels of expression, which are prominent even in bright®eld photomicrographs ( Fig. 3G ) due to the heavy distribution of emulsion granules, were detected throughout the tissue (Fig. 3I) . In explants treated with IM plus sFRP-1, a punctate pattern was apparent in bright®eld ( Fig. 3H) , and the overall level of expression appeared to be markedly reduced ( Fig. 3J ) relative to IM-treated explants.
Using sfrp-2 as a marker for tubulogenesis in explants, intense expression was demonstrable throughout the forming epithelia (Fig. 3K,M) . Furthermore, the expression occurred in pretubular aggregates, but not in areas of condensed mesenchyme. In cultures treated with sFRP-1 protein, the expression of sfrp-2 was weak and approached background levels (Fig. 3L, N) . No foci of expression were apparent in these cultures.
To provide further evidence for the inhibition of epithelial conversion by sFRP-1, E-cadherin expression, which is widely used as an epithelial marker, was analyzed by immunohistochemistry. E-cadherin is expressed in newly formed tubules of the metanephros and its expression pattern has been described in detail (Vestweber et al., 1985; Cho et al., 1998) . In IM-treated explants, E-cadherin expression was clearly demonstrated in tubular structures (Fig. 3O) , while its expression was absent in explants treated with IM plus sFRP-1 (Fig. 3P) .
Thus, in light of our ®ndings for lim-1, sfrp-2 and Ecadherin expression, it appears that sFRP-1 blocks not only the morphogenesis associated with tubulogenesis, but also molecular events associated with epithelial differentiation.
Binding of sFRP-1 to Wnt family members
Investigations by others have demonstrated a complementarity of expression patterns for wnt and sfrp molecules in tissues for which sFRP antagonism has been described (Leyns et al., 1997; Wang et al., 1997) . Additionally, wnt-4 expression has been reported in induced cultures of metanephric mesenchyme (Karavanova et al., 1996) , and thus far, it is the only Wnt family member associated with the differentiation of this mesenchyme. To determine if the sFRP-1 protein binds Wnt-4 and antagonizes its activity, we ®rst tested the ability of the protein to interact with Wnt-4 in an ELISA. For this, cell lysates were prepared from RatB1a ®broblasts transfected with HA-tagged Wnt-4 expression vector, Wnt-3A expression vector, or an empty control vector (Shimizu et al., 1997) . Using increasing concentrations of lysate, Wnt-4 showed saturable binding with an avidity greater than that for Wnt-3A (Fig. 4) . This result indicated that sFRP-1 can bind to Wnt-4, supporting the notion that it could modulate Wnt-4 activity in vivo.
TCF activity is reduced by sFRP-1 but not by sFRP-2 in metanephric mesenchyme
Signaling by Wnt leads to an accumulation of cytoplasmic beta-catenin, allowing its nuclear translocation as a complex with a member of the TCF transcription family. This active complex recognizes speci®c DNA-binding sites to regulate the transcription of target genes. Although there is no direct evidence for the accumulation of cytoplasmic beta-catenin as a result of Wnt-4 signaling, the misexpression of Wnt-4 or beta-catenin in chicken limb development caused similar histological and molecular phenotypes, suggesting that Wnt-4 signal is mediated by a beta-catenin/TCF complex (Hartmann and Tabin, 2000) . To determine if the inhibitory effect of sFRP-1 on tubule formation is associated with an inhibition of Wnt signaling and TCF activity, an electrophoretic mobility shift assay (EMSA) was employed. In mesenchymes cultured in IM, one predominant band was detected using a labeled TCF-binding oligonucleotide, indicating the formation of a TCF/DNA complex (Fig. 5, lane 4) . Without nuclear extracts, the band was not observed (lane 1). Pre-incubation of the nuclear extracts with an excess amount of unlabeled wildtype TCF-binding probe signi®cantly reduced the band intensity (lane 2), while an unlabeled mutant-type motif did not alter the intensity (lane 3), showing the speci®city of this binding. In the presence of sFRP-1, the band intensity was markedly reduced (lane 5). This provides additional evidence supporting the hypothesis that sFRP-1 can act as an antagonist of Wnt-4 signaling in the metanephric mesenchyme. On the other hand, sFRP-2 did not reduce the band intensity (lane 6) despite its reported interaction with Wnt-4 (Lescher et al., 1998) .
Discussion
Multiple sfrps are expressed at high levels during renal development in tissue-speci®c patterns, which complement or overlap the expression of the Wnt family members. In an effort to better understand how these putative modulators of Wnt signaling might function in vivo, we evaluated the ability of sFRP-1 to in¯uence the morphogenesis of the metanephric mesenchyme, a process shown by gene targeting to be dependent upon Wnt-4 signaling (Stark et al., 1994) . In these studies, we have found that sFRP-1 is capable of interacting with Wnt-4 protein and blocking morphogenetic and molecular events associated with Wnt-4 signaling. We also found that sFRP-2 competes with sFRP-1 to facilitate tubulogenesis and bud branching.
Comparison of sfrp expression in rat and mouse
Our studies show that sfrp-1 is expressed in the developing rat kidney in a manner similar to that described for the mouse (Leimeister et al., 1998) . During organogenesis, it appears early and in a tissue-speci®c pattern, i.e. it is detected only in stromal elements, including those that surround the induced tubule-generating blastemal tissues. With our probe, it is speci®cally absent from any epithelial structure in the metanephros. This differs somewhat from the report for the mouse, in which expression was observed to shift from the stroma to the epithelium of the nephron as development progressed, since we detected no expression in the epithelia even at later stages. This may simply indicate differing sensitivities of probes or experimental conditions, although it may also re¯ect bona ®de species distinctions. Conversely, sfrp-2 expression occurs primarily in newly formed epithelia, with the exception of the tissue immediately around the ureter, in a pattern that is complementary to sfrp-1 expression, suggesting distinct functions in renal development. The pattern of sfrp-2 expression also differs slightly between species. In the rat, it is clearly demonstrable in pretubular aggregates, which consist of polarized epithelia beneath the bud tip, but not in condensed mesenchyme at the bud tip as observed in mice.
sFRP-1 inhibits tubule formation and bud growth in metanephroi
The metanephros in Wnt-4 null homozygotes is de®cient not only in tubule formation, but also in the extent of ureteric bud branching in comparison with normal metanephroi (Kispert et al., 1996) . In our experiments, signi®cant inhibition of tubule formation and bud growth by sFRP-1 was demonstrated. Although we have not elucidated the mechanism for its inhibitory effects on the bud, there are some possible interpretations. Mesenchymal differentiation and bud growth are driven by reciprocal inductive factors. Soluble signals from the metanephric mesenchyme, such as the glial cell line-derived neurotrophic factor (GDNF) and other(s), are required for bud growth and branching (Qiao et al., 1999) . It is possible that treatment with sFRP-1 reduces the production of these necessary soluble signaling factors in the metanephric mesenchyme. Alternatively, sFRP-1 may inhibit bud growth directly by regulating Wnt signaling in the ureteric bud. Wnt-7B, which is expressed in collecting ducts, and Wnt-11, which is expressed at bud tips, would be likely candidate molecules, although the functional role of these Wnts in kidney development has not been established. 
sFRP-1 activity is speci®c to late events in morphogenesis
Of particular interest are the noted expression pro®les for markers of kidney development in our explant cultures. While wt1 seems to be appropriately expressed in the presence and absence of sFRP-1, lim-1 expression is decreased in the presence of sFRP-1 and occurs in a punctate manner. Based on its distribution in vivo in pretubular aggregates and primitive epithelial structures, this observation suggests that some polarization or epithelial conversion of mesenchymal cells has occurred in sFRP-1-treated cultures, but that these cells have failed to expand in number. While we have not ruled out the possibility that a higher concentration of sFRP-1 might completely eliminate the punctate pattern, an alternative interpretation might be that Wnt-4 does not initiate the epithelial conversion of metanephric mesenchyme, but rather stimulates the burst of epithelial cell proliferation that accompanies the conversion process. This is supported by the fact that FGF2 causes explanted metanephric mesenchyme to condense and express early markers of development, including wnt-4 (unpublished observation); however, FGF2 is only weakly inductive for tubule formation (Karavanov et al., 1998) .
sFRP interactions with Wnts
Since Wnt-4 has been shown to mediate events involved in the epithelial conversion of the metanephric mesenchyme or in tubule elongation, sFRP-1 might modulate these activities through a direct interaction with Wnt-4. Indeed, sFRP-1/Wnt-4 binding was observed in our experiments. sFRP-1 bound Wnt-4 with an avidity greater than that demonstrated for Wnt-3A, whose dorsal axis-duplicating activity in Xenopus embryos was only marginally affected by concomitant sFRP-1 expression (Finch et al., 1997) . Another possibility is that our bud cell conditioned medium contains a soluble Wnt that is responsible for the induction of tubule formation in our explant system, and that sFRP-1 interaction with Wnt-4 in the mesenchymes is not the principal mechanism causing the inhibition of morphogenesis. While Wnt proteins have been detected in soluble form (Bradley and Brown, 1995) , most often, they associate with extracellular matrix components upon secretion and are rarely detected in culture medium from Wnt-expressing cells (Papkoff and Schryver, 1990) . Thus, Wnt-expressing cells themselves are required for inductive signaling (Herzlinger et al., 1994) . We have attempted to address this issue by depleting potential Wnts from bud conditioned medium using sFRP-1-coated plates, but have been unable to detect any loss of inductive activity in such experiments (unpublished observation), suggesting that sFRP-1 is not regulating tubulogenesis through interaction with a soluble Wnt in conditioned medium.
Although binding of sFRPs and Wnts is presumably required to antagonize Wnt signaling, binding per se is not necessarily suf®cient to prevent this signaling. Frzb-1, for example, coimmunoprecipitates with Wnt-5A, suggesting that it interacts with the Wnt protein, but it does not block Wnt-5A signaling in a Xenopus functional assay for Wnt-mediated axis duplication. However, Frzb-1 both associated with and blocked Wnt-1 signaling .
The sFRPs have been implicated principally as antagonists of Wnt signaling, perhaps as proteins that can bind and sequester active Wnt proteins. Frzb and Xwnt-8 are expressed in complementary patterns during embryogenesis, and Frzb binds to Xwnt-8. Furthermore, it apparently inacti- Fig. 5 . Inhibition of TCF DNA-binding activity in sFRP-1-treated induced metanephric mesenchymes. Isolated metanephric mesenchymes (13-dpc) were cultured in IM for 3 days with or without sFRPs (10 mg/ml). The DNA-binding by TCF was analyzed by EMSA as described in Section 4. In cultures grown in IM, one predominant band (arrow) is detected (lane 4). Without nuclear extracts, this band is not observed (lane 1). The intensity of this band is signi®cantly reduced by pre-incubation with the 80-fold excess amount of unlabeled wild-type oligonucleotide (lane 2), but not with mutant oligonucleotide (lane 3). In the presence of sFRP-1, the band intensity is signi®cantly reduced (lane 5). However, sFRP-2 does not diminish the band intensity (lane 6).
vates Xwnt-8 during gastrulation to promote dorsalization of the Xenopus embryo (Leyns et al., 1997; Wang et al., 1997) and prevents the induction of MyoD in a manner similar to that reported for a dominant-negative form of Xwnt-8 (Hoppler et al., 1996) . In the current studies, sFRP-1 was applied to a well-characterized biological model for tubulogenesis of the metanephric mesenchyme, and it completely blocked tubule formation in isolated mesenchymes and metanephroi, providing the ®rst evidence for participation of sFRPs in organogenesis as well. While we cannot prove that this antagonism results from the direct interaction of sFRP-1 and Wnt-4, instead of an as yet unidenti®ed Wnt family member, the circumstances are comparable with those described above for Frzb and Xwnt-8. Both molecules are expressed in a complementary manner; they are interactive; a morphogenetic event associated with Wnt-4 activity (epithelial conversion/tubule formation) is inhibited by sFRP-1; and sFRP-1 limits or blocks the expression of molecules associated with Wnt-4 signaling, namely sfrp-2 (Lescher et al., 1998) , and the activation of TCF.
Function of sFRPs in vivo
Finally, as mentioned above, direct interaction of sFRP and Wnt molecules does not necessarily mean that Wnt signaling will be blocked. Recently, we observed that sFRP-1 can have a biphasic effect on Wnt-dependent stabilization of Armadillo (Drosophila ortholog of beta-catenin), potentiating Wnt activity at low concentrations, but inhibiting it at high concentrations, comparable with those used in the current study (U È ren et al., 2000) . This raises the possibility that the response to sFRP-1 in vivo could be strictly dependent on the proximity to its sites of synthesis, i.e. near abundant sources, high concentrations of sFRP-1 would be expected to block Wnt signaling, whereas at a distance, low concentrations might enhance Wnt activity. Such a pattern has been described for the regulation of Decapentaplegic (Dpp) by the protein, Short gastrulation (Sog), which binds Dpp and inhibits its activity on adjacent cells, but enhances signaling in a distant cell population (Ashe and Levine, 1999) . Thus, sFRP-1 might function to exclude nephrogenesis from regions of the developing kidney where it is expressed and promote nephron formation at distant sites. The role of sFRP-2 in tubulogenesis would appear to follow a different pattern. Since sfrp-2 is concurrently expressed with wnt-4 in the newly formed epithelia, it is dif®cult to imagine a similar local antagonistic function such as the one proposed for sFRP-1. It is more likely that a high local concentration of sFRP-2 would facilitate Wnt-4 activity. This hypothesis is supported by our ®nding that sFRP-2 competes with sFRP-1 to promote tubulogenesis. There is a precedent for sFRP-1 and sFRP-2 having opposing effects on the same cells (Melkonyan et al., 1997) , adding further credence to this hypothesis.
A direct interaction between sFRP-2 and Wnt-4 has been demonstrated previously (Lescher et al., 1998) , and cells expressing sFRP-2 can reduce the dermomyotome-inducing activity of Wnt-4 in cultured presomitic mesoderm explants (Lee et al., 2000) . These observations indicate a possible antagonism of Wnt-4 signaling by sFRP-2. However, as shown herein, the DNA-binding activity of TCF in Wnt-4 expressing mesenchyme is not reduced by sFRP-2, indicating that sFRP-2 does not antagonize Wnt-4 signaling in the metanephric mesenchyme. Thus, the effect of sFRPs on Wnt signaling may differ in diverse cell populations and may re¯ect varying af®nities for different frizzled receptor and/ or associated proteoglycan. The latter has an important role in Wnt-dependent kidney morphogenesis (Davies et al., 1995) and can modulate sFRP/Wnt interactions (U È ren et al., 2000) .
In conclusion, these studies demonstrate that sFRP-1 can behave as an effective antagonist of Wnt signaling in metanephroi and explant cultures of induced metanephric mesenchyme. Additionally, it is expressed in a complementary pattern to wnt-4 during kidney development and physically interacts with the Wnt-4 protein in vitro. Due to its extensive expression throughout the metanephros in stromal tissues and the known ability of cells that express sfrps to secrete them (Leyns et al., 1997; Wang et al., 1997; Finch et al., 1997; Rattner et al., 1997) , our ®ndings implicate this molecule in the regulation of tubule formation during organogenesis. However, its exact function in this process remains to be established. Perhaps it is critical to the maintenance of blastemal cells in the nephrogenic zone of the metanephric cortex. The expansion of renal tissue is dependent upon differentiation in a proximal±distal pattern with the least differentiated tissues existing in the cortical region. The stem cells for subsequent rounds of tubular formation therefore populate the outer region of the cortex and are directly juxtaposed to a capsular sFRP-1-secreting stromal layer. Thus, sFRP-1 may help to maintain the blastemal stem cell population by preventing Wnt-dependent differentiation. Due to the high levels expressed around the ureter and within the medulla of the metanephros, another possibility is that it prevents ductal/tubular expansion in mature tissues, and as such, may function as a suppressor of inappropriate differentiation. Since sFRP-2 is also expressed in tissues surrounding the ureter, co-expression of these sFRPs may indicate both positive and negative regulation of ureter growth, but further study of such a complex relationship will be required.
Experimental procedures
Probes
A 480-bp fragment (sfrp-1) and a 586-bp fragment (sfrp-2), based upon mouse sequences, were generated by RT-PCR from 19-dpc rat kidney RNA. The primers used in PCR were 5
forward) and 5 H -CTTGCGGATGCTGCGGGAGATG-3 H (sfrp-2, reverse). Ampli®ed fragments were cloned into a pGEM-T Easy Vector (Promega), and sequenced with SP6 primer. Probes for wt1 and lim-1 were prepared as previously described (Perantoni et al., 1995; Karavanova et al., 1996) .
In situ hybridization
Tissue explants and resected rat metanephroi (16-and 19-dpc) were ®xed with 4% paraformaldehyde (PFA) in PBS. For explants, tissues grown on ®lters were¯oated for 2 h on PFA, washed once in PBS, incubated for 10 min in 50% ethanol in PBS, and ®nally washed twice for 10 min each in 70% ethanol. Metanephroi were ®xed overnight, then exposed to a similar regimen, except that tissues were incubated in ethanol washes for 1 h. In situ hybridization analyses were performed using 35 S-labeled riboprobes according to Wilkinson and Green (1990) .
Recombinant sFRP-1 and sFRP-2
A human sfrp-1 NotI-SmaI cDNA fragment (Finch et al., 1997) was cloned into an XhoI site in a pcDNA3.1 expression vector, expressed in Madin-Darby canine kidney (MDCK) cells, and puri®ed by heparin-af®nity chromatography as described (U È ren et al., 2000) . For sFRP-2, a rat cDNA fragment was cloned and the same protocol for sFRP-1 was used for expression and puri®cation.
Cultures of isolated metanephroi
Rat metanephroi (13-dpc) were surgically extracted and cultured on ®lters (three/®lter). The culture medium contained a basal medium (DMEM/F12, 50:50 mix), 10% fetal bovine serum and sFRP-1 (5 or 10 mg/ml), or sFRP-2 (10 mg/ml) or combinations of these sFRPs. The culture medium was replaced every 48 h. After 5 days, tissues were ®xed for subsequent double-staining. All experiments were repeated at least twice.
Double-staining of cultured metanephroi
Tissues were ®xed with 100% methanol at 2208C for 10 min, washed in Tris-buffered saline (TBS; pH 7.4), and blocked in 10% sheep serum/TBS for 5 h. Incubation with anti-E-cadherin antibody (1:50, Santa Cruz Biotechnology, Inc.) was performed at 48C for 48 h. Secondary antibody reactions were done with Rhodamine-conjugated anti-rabbit antibody (Santa Cruz Biotechnology, Inc.) at a 1:100 dilution overnight after an 8-h wash in 1% sheep serum/TBS. After washing in TBS, tissues were stained with FITCconjugated DB-lectin (20 mg/ml; Sigma) for 1 h, and then washed and ®xed with 4% PFA for 30 min. For confocal analysis, tissues were mounted in 50% glycerol/TBS and images were collected with a laser-scanning confocal microscope (Bio-Rad MRC 1024).
Culture conditions for metanephric mesenchymes
Metanephroi from 13-dpc rats were surgically extracted and non-induced metanephric mesenchyme was isolated as previously described (Perantoni et al., 1995) . Mesenchymes (generally four/®lter) were placed on collagen IV-coated Nucleopore ®lters (0.1 mm pore size), and the ®lters werē oated on 1-ml medium in a 12-well tissue culture plate. The serum-free medium conditions were as previously described (Karavanova et al., 1996) . Brie¯y, a basal medium (DMEM/F12, 50:50 mix), containing transferrin, hydrocortisone, triiodothyronine, insulin, prostaglandin E1, and selenium, was further supplemented with transforming growth factor-a (10 ng/ml), FGF2 (50 ng/ml), and cell culture medium conditioned by a cell line derived from rat ureteric bud (33 ml/ml). The cultures were placed in a humidi®ed incubator with continuous¯ow CO 2 (5%) and air. The explants were monitored for 3 days and then ®xed.
Immunohistochemistry
Sectioned tissue explants were dewaxed, blocked with methanol and incubated with a 1:400 dilution of the anti-E-cadherin antibody (Santa Cruz Biotechnology, Inc.). Signals were detected using the VECTASTAIN Elite ABC Kit (Vector Laboratories) according to the manufacturer's instructions.
Immunoblotting
RatB1a ®broblasts transfected with HA-tagged retroviral Wnt-4, Wnt-3A expression vector, or an empty control vector were grown in DMEM (Gibco-BRL) containing 7.5% calf serum (Gibco-BRL) and 2.5% fetal calf serum (Colorado Serum Co.; Shimizu et al., 1997) . A clonal line was used that expressed Wnt-3A at a level comparable with Wnt-4 expression in the corresponding mass culture. Con¯uent cultures (10-cm dishes) were washed twice with cold PBS and treated with 0.3 ml lysis buffer (50 mM HEPES (pH 7.5); 1% Triton X-100; 50 mM NaCl; 5 mM EDTA; 50 mM EDTA; 50 mM NaF; 6.7 mM sodium phosphate; 1 mM sodium vanadate; 10 mg/ml aprotinin; 10 mg/ ml leupeptin; and 1 mM PMSF). Aliquots of lysates (50 mg total protein) were resolved in 8% SDS PAGE gels and transferred to Immobilon-P membranes. The membranes were blocked with 3% non-fat dry milk in 1% Triton X-100/Tris-buffered saline (TTBS) for 2 h and incubated overnight with 0.4 mg/ml anti-HA monoclonal antibody (Roche) in 0.5% BSA/TTBS. Proteins were visualized using an ECL Western blotting system (Amersham) and X-Omat AR ®lm (Kodak) according to the manufacturer's instructions.
ELISA
Wnt binding to sFRP-1-coated wells was performed as described (U È ren et al., 2000) , except that cell lysates were used instead of conditioned medium and HA-tagged Wnt proteins were detected with 0.4 mg/ml anti-HA monoclonal antibody (Roche).
Nuclear extract preparation
Thirty-six metanephric mesenchymes (13-dpc) were cultured for 3 days on ®lters in IM with or without 10 mg/ ml of puri®ed recombinant sFRP1 or sFRP-2. Nuclear extracts were prepared as described previously (Dignam et al., 1983) . To strip cells, the ®lters were combined and vortexed for 10 s in 1 ml of ice-cold PBS. The cells were spun down for 1 min at 3000 rev./min, and then resuspended in 300 ml of cold buffer A (10 mM HEPES (pH 7.4); 1.5 mM MgCl 2 ; 10 mM KCl; 0.5 mM DTT) with protease inhibitors Complete e (Roche) and incubated on ice for 10 min. The nuclei were collected by centrifugation at 7000 rev./min for 1 min at 48C. The supernatant was removed, and the nuclei were re-suspended in 50 ml of cold buffer B (20 mM HEPES (pH 7.4); 1.5 mM MgCl 2 ; 400 mM NaCl; 0.5 mM DTT; 0.2 mM EDTA; 20% glycerol with protease inhibitors Complete e ) and incubated on ice for 30 min, followed by centrifugation at 14 000 rev./min for 30 min. The protein concentrations were determined using Bio-Rad protein assay dye reagent. Nuclear extracts were quickly frozen in liquid nitrogen and stored at 2708C. From 36 metanephric explants, 10±15 mg of nuclear proteins was obtained.
EMSA
The DNA-binding reaction was performed for 30 min at room temperature in a volume of 25 ml, containing 0.5 mg of nuclear protein extract in 5 ml of buffer B, 7.5 mg of acetylated bovine serum albumin (Promega), 0.5 mg of sonicated salmon sperm DNA (Stratagene), and 0.5 ng of 32 P-radiolabeled probe (1 £ 10 5 cpm) with or without an 80-fold molar excess of cold competitor DNA. For the optimal TCF/LEFbinding sites, we used double-stranded oligonucleotides GGTACCCCCTTTGATCTTACCAAGCTT (TCF-wt) and GGTACCCCCTTTGGCCTTACCAAGCTT (TCF-mut), synthesized according to Korinek et al. (1997) and puri®ed from 10% polyacrylamide gels.
